ClearEdge DANA, an FDA-cleared Class II clinical neurocognitive tool developed by Anthrotronix Inc., measures and monitors subtle changes in cognitive function. ClearEdge DANA is efficient and effective for a wide range of preventive and acute healthcare uses.

These include:

Preventive Care

  • Assess medical and psychological states.
  • Track changes in cognitive performance over time.
  • Screen for co-morbid conditions, such as depression, insomnia and fatigue.
  • Determine the onset of cognitive disorders, like Alzheimer’s disease.

Geriatric Care

  • Monitor changes in cognitive efficiency over time to inform necessary lifestyle modifications.
  • Promote quality of life in conjunction with wellness exams.

Rehabilitative Care

  • Assess the severity of head injury and concussion.
  • Monitor changes and measure progress or decline after a stroke, illness, injury or other neurological incident.
  • Track detailed changes in cognitive performance throughout treatment and recovery.

Reports

Comprehensive patient test reports detail the results of the cognitive assessments, providing baselines and data for comparison over multiple testing sessions.